{
  "pmcid": "9983301",
  "sha256": "dc922ee43a9512561fb8be2a8cc2b4acfd59b9d0204b35d8a39b34d871395c6b",
  "timestamp_utc": "2025-11-09T16:23:13.123576+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.9107371180156,
    "reading_ease": 16.82276765545754,
    "word_count": 869
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "We included randomized controlled trials (RCTs) conducted in preterm and term infants"
      },
      "Participants": {
        "score": 2,
        "evidence": "preterm and term infants of a postmenstrual age up to 46 weeks and 0 days with postoperative pain"
      },
      "Intervention": {
        "score": 2,
        "evidence": "systemic opioids were compared to 1) placebo or no intervention; 2) non‐pharmacological interventions; 3) different types of opioids; or 4) other drugs"
      },
      "Objective": {
        "score": 1,
        "evidence": "To evaluate the benefits and harms of systemic opioid analgesics in neonates who underwent surgery"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Our primary outcomes were pain assessed with validated methods, all‐cause mortality during initial hospitalization, major neurodevelopmental disability, and cognitive and educational outcomes in children more than five years old"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "We included four RCTs enrolling 331 infants in four countries across different continents"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The evidence is very uncertain about the effect of tramadol compared with placebo on all‐cause mortality during initial hospitalization (RR 0.32, 95% Confidence Interval (CI) 0.01 to 7.70; RD ‐0.03, 95% CI ‐0.10 to 0.05, 71 participants, 1 study; I² = not applicable)"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}